INTERNATIONAL PATENT: MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. FILES APPLICATION FOR "THERAPEUTIC VARIABLE DOMAIN OF HEAVY CHAIN (VHH) ANTIBODIES AGAINST BASIGIN (CD147) AND THEIR USE FOR BLOCKING PLASMODIUM FALCIPARUM ENTRY INTO HUMAN ERYTHROCYTES"

GENEVA, Jan. 26 -- MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (HofgartenstraBe 880539 Munchen) filed a patent application (PCT/EP2025/070453) for "THERAPEUTIC VARIABLE DOMAIN OF HEAVY CHAIN (VHH) ANTIBODIES AGAINST BASIGIN (CD147) AND THEIR USE FOR BLOCKING PLASMODIUM FALCIPARUM ENTRY INTO HUMAN ERYTHROCYTES" on Jul 17, 2025. With publication no. WO/2026/017779, the details related to the patent application was published on Jan 22, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GORLICH, Dirk (c/o Max-Planck-Institut fur MultidisziplinareNaturwissenschaften, Am FaBberg 113...